Launch of a sponsorship partnership with BNP Paribas Cardif

This commitment to the Institute is particularly important for BNP Paribas Cardif. While accelerating projects with a high transfer potential for the benefit of patients and intended for the creation of start-ups, BNP Paribas Cardif's aim is to raise awareness among its employees, partners and policyholders, with the aim of improving their knowledge of genetic diseases.

"As an insurer, BNP Paribas Cardif also has a responsibility to be involved in society and particularly in medical research. The work of the Imagine Institute is remarkable and we are proud to be able to contribute to their research, while at the same time advancing our product and service offerings, in order to better cover the populations affected by rare diseases," says Fabrice Bagne, Deputy CEO of BNP Paribas Cardif, responsible for France and Luxembourg.

"Since our aim is to bring treatments to patients as quickly as possible, we have created a unique acceleration tool, Springboard, whose ambition is to finance and grow projects with a view to creating start-ups. We are delighted that BNP Paribas Cardif is supporting this innovative value-creation scheme, which will change the lives of many families affected by genetic diseases", says Professor Stanislas Lyonnet, Director of the Imagine Institute.

Within the Springboard scheme, BNP Paribas Cardif is supporting a group of three high-potential projects:

• The HERMES project led by Laurence Legeai-Mallet, whose objective is to develop a molecule extracted from cocoa, "epicatechin", which has been shown to be effective in combating certain bone growth anomalies. To find out more about this project. Read more
• The IMAG2 project led by Sabine Sarnacki and Isabelle Bloch aims to develop a 3D modelling technology which, thanks to artificial intelligence techniques, will make it possible to better prepare the surgical strategy, but also to better explain to the child and his or her family the nature of the operation that is going to be carried out and the issues involved. Read more
• The CHILDREN'S PAIN project led by Céline Greco and Patrick Delmas (CRN2M) whose ambition is to treat pain in various skin diseases by a strategy of repositioning molecules and drugs.  On this same theme, Céline Greco is also in charge of the PRELUDE programme, which includes four clinical research projects and two fundamental research projects. Find out more about the PRELUDE project.Read more about PRELUDE

This BNP Paribas Cardif x Institut Imagine sponsorship partnership is also a perfect illustration of the obvious synergies between the Innovation and Valorisation Department (DIVA), headed by Hélène Chautard, and the Development and International Philanthropy team, headed by Laurent Mellier, which, when they combine their complementary expertise and strengths, result in significant and lasting support for the Institute.